Saturday 17 October 2026 Export SUPN’s income statement to Excel — free account

Supernus Pharmaceuticals, Inc.

SUPN Healthcare Drug Manufacturers Specialty & Generic

Supernus Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $719.0 million, up 8.63% from fiscal 2024. In the quarter to June 2026, revenue grew 32.4%, EPS fell 352.5% and free cash flow fell 109.3%, each against the same quarter a year earlier.

37.88 1.69 −4.27%

Follow SUPN

Alert me

Market cap: $2.3B
P/E: 0.0×
Fwd P/E: 103×
Dividend yield: —
F-score: 5/9
Altman Z: 5.41
Beneish M: −2.54
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	3.25	3.84	3.90	3.97
P/FCF ratio Full definition →	161.27	37.09	63.18	39.07
P/Operating CF Full definition →	(561.50)	44.79	141.26	(43.83)
P/B ratio Full definition →	2.62	2.77	2.64	2.57
Price to Tangible BV Full definition →	6.11	7.33	7.64	8.80
EV/Sales Full definition →	3.38	3.96	4.14	4.26
EV/EBITDA Full definition →	0.00	84.68	107.23	63.39
EV/Operating CF Full definition →	141.00	36.93	62.87	40.35
EV/FCF Full definition →	167.64	38.27	67.01	41.93
Quick Ratio Full definition →	1.68	1.51	1.47	1.37
Current Ratio Full definition →	2.08	1.96	1.90	1.80
Net Debt/EBITDA Full definition →	11.43	(21.82)	(14.31)	7.74
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.59	0.55	0.51	0.49
Operating CF/Net income Full definition →	0.08	(29.01)	(4.84)	1.37
Capex/Depreciation Full definition →	(0.02)	0.00	(0.02)	(0.01)
Interest Coverage Full definition →	(25.04)	—	—	—
Research and Development Expense of Revenue Full definition →	13.45%	18.99%	13.15%	15.29%
Selling, General and Administrative Expense of Revenue Full definition →	61.01%	60.26%	57.85%	93.53%
Intangible Assets out of Total Assets Full definition →	0.41	0.45	0.48	0.52
Share Based Compensation of Revenue Full definition →	3.94%	4.08%	4.56%	4.07%
Graham Net Nets Full definition →	0.12	0.10	0.09	0.08
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(4.13%)	(0.99%)	(1.37%)	(0.69%)
Free Cash Flow Yield Full definition →	0.62%	2.70%	1.58%	2.56%
Revenue per Share Full definition →	3.77	3.60	3.75	3.40
Operating CF per Share Full definition →	(0.08)	1.15	0.35	(1.09)
Capex per Share Full definition →	(0.01)	0.00	(0.01)	0.00
Free Cash Flow per Share Full definition →	(0.09)	1.15	0.34	(1.09)
Cash per Share Full definition →	6.41	6.67	5.47	4.97
Shareholders Equity per Share Full definition →	17.76	18.68	18.81	18.56
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	17.76	18.68	18.81	18.56
Free Cash Flow Full definition →	(5.38)	66.52	19.43	(61.79)
Working Capital Full definition →	376.12	357.65	306.01	263.26
Capital Expenditures Full definition →	(0.57)	—	(0.43)	(0.13)
Net Current Asset Value Full definition →	326.61	307.66	253.25	223.80
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.00
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	176.24	163.91	164.94	158.33
Average Payables Full definition →	93.10	89.07	92.08	92.21
Average Inventory Full definition →	63.97	68.24	68.34	71.69
Average Assets Full definition →	1,405.26	1,424.01	1,410.36	1,381.23
Average Common Equity Full definition →	1,047.56	1,053.76	1,048.72	1,028.41

Show all line items

Columns are period end dates

Stockrow Weekly